Journal of Commercial Biotechnology is now archived and no
longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites.
Volume 9, issue 4, June 2003
11 articles in this issue
-
-
Opinion piece: Biotechnology's growth–innovation paradox and the new model for success
Authors
- Ann Baker
- Content type: Paper
- Published: 01 June 2003
- Pages: 286 - 288
-
Life after Enron and ImClone: Special concerns for the biotechnology company
Authors
- Neil H Aronson
- Content type: Paper
- Published: 01 June 2003
- Pages: 289 - 296
-
The key to successful collaborations: Rigorous and independent due diligence
Authors
- Ian Rhodes
- Craig Nelson
- Gregory Berman
- Content type: Paper
- Published: 01 June 2003
- Pages: 297 - 304
-
Dominating global intellectual property: Overview of patentability in the USA, Europe and Japan
Authors
- Thomas J Kowalski
- Antonio Maschio
- Samuel H Megerditchian
- Content type: Paper
- Published: 01 June 2003
- Pages: 305 - 331
-
Patent issues and future trends in drug development
Authors
- Faiz Kermani
- Pietro Bonacossa
- Content type: Paper
- Published: 01 June 2003
- Pages: 332 - 338
-
Strategies for building a global healthcare biotechnology company
Authors
- James A Geraghty
- Content type: Paper
- Published: 01 June 2003
- Pages: 339 - 344
-
Regulatory Submissions Trends Survey 2002
Authors
- Ellen Semple
- Content type: Paper
- Published: 01 June 2003
- Pages: 345 - 357
-
Marketspace: Trends in biotherapeutics
Authors
- Alex K Pavlou
- Content type: Paper
- Published: 01 June 2003
- Pages: 358 - 363
-
Legal and regulatory update: Voluntary withdrawal of marketing authorisations and consequences for parallel importers
Authors
- John Wilkinson
- Content type: Miscellaneous
- Published: 01 June 2003
- Pages: 364 - 371
-
EU Financial accounts reports
Authors
- David Citron
- Content type: Miscellaneous
- Published: 01 June 2003
- Pages: 372 - 374